The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Determining breast cancer biomarker status and associated morphological features using deep learning
Open accessAbstract
Background: Breast cancer management depends on biomarkers including estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (ER/PR/HER2). Though existing scoring systems are widely used and well-validated, they can involve costly preparation and variable interpretation. Additionally, discordances between histology and expected biomarker findings can prompt repeat testing to address biological, interpretative, or technical reasons for unexpected results. Methods: We developed three independent deep learning systems (DLS) to directly predict ER/PR/HER2 status for both focal tissue regions (patches) and slides using hematoxylin-and-eosin-stained (H&E) images as input. Models were trained and evaluated using pathologist annotated slides from three data sources. Areas under the receiver operator characteristic curve (AUCs) were calculated for test sets at both a patch-level (>135 million patches, 181 slides) and slide-level ( n = 3274 slides, 1249 cases, 37 sites). Interpretability analyses were performed using Testing with Concept Activation Vectors (TCAV), saliency analysis, and pathologist review of clustered patches. Results: The patch-level AUCs are 0.939 (95%CI 0.936–0.941), 0.938 (0.936–0.940), and 0.808 (0.802–0.813) for ER/PR/HER2, respectively. At the slide level, AUCs are 0.86 (95%CI 0.84–0.87), 0.75 (0.73–0.77), and 0.60 (0.56–0.64) for ER/PR/HER2, respectively. Interpretability analyses show known biomarker-histomorphology associations including associations of low-grade and lobular histology with ER/PR positivity, and increased inflammatory infiltrates with triple-negative staining. Conclusions: This study presents rapid breast cancer biomarker estimation from routine H&E slides and builds on prior advances by prioritizing interpretability of computationally learned features in the context of existing pathological knowledge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which may result from prognostic information also partially explained via genomics as aberrations such as ERBB2 or KRAS mutation and the presence of microsatellite instability can be determined from histology (Coudray et al., 2018;Kather et al.,2019,2020;Gamble et al.,2021).”
From Pan-cancer integrative histology-genomic analysis via multimodal deep learning (2022) · cites this paper as Gamble et al.,2021
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rethinking the Inception Architecture for Computer Vision
Szegedy, C., Vanhoucke, V., Ioffe, S., Shlens, J., & Wojna, Z. (2016) · 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr.2016.308 · Cited by 32,138
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Breast Cancer Treatment: A Review
Waks, A. G., & Winer, E. P. (2019) · JAMA · doi:10.1001/jama.2018.19323 · Cited by 4,804 · cited 1×
“These biomarkers include estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) 1 .”
BackgroundCoudray, N., Ocampo, P. S., Sakellaropoulos, T., Narula, N., Snuderl, M., Fenyö, D., Moreira, A. L., Razavian, N., & Tsirigos, A. (2018) · Nature Medicine · doi:10.1038/s41591-018-0177-5 · Cited by 2,930
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Ciriello, G., Gatza, M. L., Beck, A. H., Wilkerson, M. D., Rhie, S. K., Pastore, A., Zhang, H., McLellan, M., Yau, C., Kandoth, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.033 · Cited by 1,858 · cited 2×
“…predictions, was developed (trained and tuned) using 2134 slides from 264 cases, and evaluated on a test set containing a total of 3274 slides from 1249 cases across a tertiary hospital and The Cancer Genome Atlas (TCGA 13, 14 , representing 36 unique tissue source sites), summarized in Table 1.”
MethodEstrogen and progesterone receptor testing in breast cancer: ASCO/CAP Guideline update
Allison, K. H., Hammond, M. E. H., Dowsett, M., McKernin, S. E., Carey, L. A., Fitzgibbons, P. L., Hayes, D. F., Lakhani, S. R., Chavez-MacGregor, M., Perlmutter, J., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02309 · Cited by 1,574 · cited 1×
“This is further recognized in the 2019 American Society of Clinical Oncology (ASCO) and College of American Pathologists (CAP) guidelines, which recommend follow up for observed discordance between ER status and histologic fi ndings, such as low grade but ER-negative carcinoma 6 .”
BackgroundSmoothGrad: removing noise by adding noise
Smilkov, D., Thorat, N., Kim, B., Viégas, F., & Wattenberg, M. (2017) · arXiv · doi:10.48550/arxiv.1706.03825 · Cited by 1,467 · cited 1×
“Four of the clusters in this group were noted by pathologists as containing tumor with cribriform morphology (clusters 18, 20, 17, 9).”
BackgroundKather, J. N., Pearson, A. T., Halama, N., Jäger, D., Krause, J., Loosen, S. H., Marx, A., Boor, P., Tacke, F., Neumann, U. P., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0462-y · Cited by 1,458 · cited 2×
“With the adoption of digital work fl ows in histopathology and recent advancements in machine learning, initial efforts have explored the possibility of using algorithms to predict biomarker status from hematoxylin and eosin (H&E)-stained tissue in breast cancer 7 – 9 and other cancer types 10,11 .”
BackgroundMethod
Research works printed but not linked: 1
- Juan, D.-C. et al. Graph-RISE: Graph-Regularized Image Semantic Embedding. arXiv [cs.CV] (2019).
Cited by
Algorithmic fairness in artificial intelligence for medicine and healthcare
Chen, R. J., Wang, J. J., Williamson, D. F. K., Chen, T. Y., Lipkova, J., Lu, M. Y., Sahai, S., & Mahmood, F. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01056-8 · Cited by 750
Pan-cancer integrative histology-genomic analysis via multimodal deep learning
Chen, R. J., Lu, M. Y., Williamson, D. F. K., Chen, T. Y., Lipkova, J., Noor, Z., Shaban, M., Shady, M., Williams, M., Joo, B., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.07.004 · Cited by 660
Self-supervised learning in medicine and healthcare
Krishnan, R., Rajpurkar, P., & Topol, E. J. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00914-1 · Cited by 605
Salahuddin, Z., Woodruff, H. C., Chatterjee, A., & Lambin, P. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.105111 · Cited by 508
Meskher, H., Ragdi, T., Thakur, A. K., Ha, S., Khelfaoui, I., Sathyamurthy, R., Sharshir, S. W., Pandey, A. K., Saidur, R., Singh, P., et al. (2024) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2023.2171277 · Cited by 225
“Cancer-specific biomarker antigens are produced by each type of cancer cell (Figure 8), for example, human epidermal growth factor receptor 2 (HER2) [202], Neuron-specific enolase [203], phosphoglucomutase-like protein 5 (PGM5)[204], peptidylarginine deiminase 2 (PADI2) [205], platelet factor 4…”
Metadata
- Authors
- Gamble, P., Jaroensri, R., Wang, H., Tan, F., Moran, M., Brown, T., Flament-Auvigne, I., Rakha, E. A., Toss, M., Dabbs, D. J., Regitnig, P., Olson, N., Wren, J. H., Robinson, C., Corrado, G. S., Peng, L. H., Liu, Y., Mermel, C. H., Steiner, D. F., & Chen, P.-H. C.
- Affiliations
- Google (United States) (US)
- University of Nottingham (GB)
- UPMC Health System (US)
- University of Graz (AT)
- United States Department of Defense (US)
- Henry M. Jackson Foundation (US)
- Naval Medical Center San Diego (US)
- Corresponding author
- Steiner, David F.
- Chen, Po-Hsuan Cameron
- ORCID
- Venue
- Communications Medicine
- Published
- 2021-07-14
- Volume
- 1
- Issue
- 1
- Pages
- 14-14
- ISSN
- 2730-664X (ISSN-L)
- PMC
- PMC9037318
- OpenAlex
- W3177811843
- Semantic Scholar
- 09765c0df4848fc9621d3b823dad4dafe1798a59
- Cited by
- 154
- References
- 26
- Citations by year
- 2026: 20 · 2025: 45 · 2024: 32 · 2023: 30 · 2022: 21 · 2021: 6
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Communications Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- Henry M. Jackson Foundation
- Verily Life Sciences
- Topics
- Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, deep learning, H&E-stained slides, histomorphology, model interpretability, saliency analysis, triple-negative breast cancer, inflammatory cell infiltration, lobular histology, histopathology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Determining breast cancer biomarker status and associated morphological features using deep learning. https://app.cochat.ai/papers/10.1038/s43856-021-00013-3
- The paper
- Gamble, P., Jaroensri, R., Wang, H., Tan, F., Moran, M., Brown, T., Flament-Auvigne, I., Rakha, E. A., Toss, M., Dabbs, D. J., Regitnig, P., Olson, N., Wren, J. H., Robinson, C., Corrado, G. S., Peng, L. H., Liu, Y., Mermel, C. H., Steiner, D. F., & Chen, P.-H. C. (2021). Determining breast cancer biomarker status and associated morphological features using deep learning. Communications Medicine. https://doi.org/10.1038/s43856-021-00013-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.